抗艾滋病逆转录病毒药物对妊娠妇女和婴幼儿的安全性研究
刘帅凤 葛宪民 沈智勇 邓小娥 吴雨霏[摘要] 随着抗艾滋病逆转录病毒新药的不断研发,药物的有效性和安全性也在不断改善。然而,妊娠妇女在使用其作为预防母婴传播用药时,孕期的生理学改变影响着药物的吸收、分布、代谢和排泄。妊娠状态下,药物的毒副作用可加重对妊娠妇女和婴幼儿的影响,如何针对性地选择安全有效的药物及用药方案,始终是卫生医学领域的关键课题。
[关键词] 抗艾滋病逆转录病毒药物;预防母婴传播;妊娠妇女;婴幼儿;安全性
[中图分类号] R512.91? ? ? ? ? [文獻标识码] A? ? ? ? ? [文章编号] 1673-7210(2019)09(c)-0045-04
Safety study on anti-HIV retrovirus drugs in pregnant female and infants
LIU Shuaifeng1? ?GE Xianmin2? ?SHEN Zhiyong1? ?DENG Xiao′e3? ?WU Yufei1
1.AIDS Prevention and Treatment Center, Guangxi Center for Disease Prevention and Control, Guangxi Zhuang Autonomous Region, Nanning? ?530028, China; 2.the Administration Office, Guangxi Center for Disease Prevention and Control, Guangxi Zhuang Autonomous Region, Nanning? ?530028, China; 3.Department of Physical Examination, Guangxi Center for Disease Prevention and Control, Guangxi Zhuang Autonomous Region, Nanning? ?530028, China
[Abstract] With the continuous research and development of new anti-HIV retrovirus drugs, the effectiveness and safety of drugs are also improving. However, when they are used as preventive drugs for prevention of mother-to-child transmission of HIV ......
您现在查看是摘要页,全文长 13429 字符。